Salih J. Wakil

Salih J. Wakil

Auto-generated profile, based on publicly available information

Salih J. Wakil

Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Journal of Lipid Research
Verified
Journal Article
Open access
SWSalih J. Wakil
Salih J. Wakil
LALutfi A. Abu-Elheiga
Lutfi A. Abu-Elheiga
Fatty acids are a major energy source and important constituents of membrane lipids, and they serve as cellular signaling molecules that play an important role in the etiology of the metabolic syndrome. Acetyl-CoA carboxylases 1 and 2 (ACC1 and ACC2) catalyze the synthesis of malonyl-CoA, the substrate for fatty acid synthesis and the regulator of fatty acid oxidation. They are highly regulated and play important roles in the energy metabolism of fatty acids in animals, including humans. They are presently considered as an attractive target to regulate the human diseases of obesity, diabetes, cancer, and cardiovascular complications. In this review we discuss the role of fatty acid metabolism and its key players, ACC1 and ACC2, in animal evolution and physiology, as related to health and disease.

1 April 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LALutfi Abu-Elheiga
Lutfi Abu-Elheiga
HWHongmei Wu
Hongmei Wu
ZGZiwei Gu
Ziwei Gu
RBRubin Bressler
Rubin Bressler
SWSalih J. Wakil
Salih J. Wakil
Hepatic fat accumulation resulting from increased de novo fatty acid synthesis leads to hepatic steatosis and hepatic insulin resistance. We have shown previously that acetyl-CoA carboxylase 2 (Acc2−/−) mutant mice, when fed a high-fat (HF) or high-fat, high-carbohydrate (HFHC) diet, are protected against diet-induced obesity and maintained whole body and hepatic insulin sensitivity. To determine the effect of an ACC2 deletion on hepatic fat metabolism, we studied the regulation of the enzymes involved in the lipogenic pathway under Western HFHC dietary and de novo lipogenic conditions. After completing the HFHC regimen, Acc2−/− mutant mice were found to have lower body weight, smaller epididymal fat pads, lower blood levels of nonesterified fatty acids and triglycerides, and higher hepatic cholesterol than wild-type mice. Significant up-regulation of lipogenic enzymes and an elevation in hepatic peroxisome proliferator-activated receptor-γ (PPAR-γ) protein were found in Acc2−/− mutant mice under de novo lipogenic conditions. The increase in lipogenic enzyme levels was accompanied by up-regulation of the transcription factors, sterol regulatory element-binding proteins 1 and 2, and carbohydrate response element-binding protein. In contrast, hepatic levels of the PPAR-γ and PPAR-α proteins were significantly lower in the Acc2−/− mutant mice fed an HFHC diet. When compared with wild-type mice fed the same diet, Acc2−/− mutant mice exhibited a similar level of AKT but with a significant increase in pAKT. Hence, deleting ACC2 ameliorates the metabolic syndrome and protects against fatty liver despite increased de novo lipogenesis and dietary conditions known to induce obesity and diabetes.

13 October 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JMJianqiang Mao
Jianqiang Mao
TYTao Yang
Tao Yang
ZGZiwei Gu
Ziwei Gu
WHWilliam C. Heird
William C. Heird
MFMilton J. Finegold
Milton J. Finegold
SWSalih J. Wakil
Salih J. Wakil
Adipose tissue is one of the major sites for fatty acid synthesis and lipid storage. We generated adipose (fat)-specific ACC1 knockout (FACC1KO) mice using the aP2-Cre/loxP system. FACC1KO mice showed prenatal growth retardation; after weaning, however, their weight gain was comparable to that of wild-type (WT) mice on a normal diet. Under lipogenic conditions of fasting/re-feeding a fat-free diet, lipid accumulation in adipose tissues of FACC1KO mice was significantly decreased; this is consistent with a 50–66% reduction in the ACC activity in these tissues compared with that of WT mice. Surprisingly, FACC1KO mice manifested skeletal growth retardation phenotype accompanied by decreased chondrocyte proliferation in the growth plate and lower trabecular bone density. In addition, there was about a 30% decrease in serum insulin-like growth factor I (IGF1), and while the serum leptin level was decreased by about 50%, it did not counteract the osteopenic effects of IGF1 on the bone. Fatty acid analyses of mutant bone lipids revealed relatively higher levels of C18:2n-6 and C18:3n-3 and lower levels of their elongation C20 homologs than that of WT cohorts, leading to lower levels of C20 homologs and bone development. Moreover, aP2-Cre-mediated ACC1 inactivation in bone tissue led to a decreased number of osteoblasts but not of osteoclasts. The downregulation of ACC1 on osteoblastogenesis may be the cause for the osteopenia phenotype of FACC1KO bone homeostasis.

11 May 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SKShinji Kamisuki
Shinji Kamisuki
TSTakashi Shirakawa
Takashi Shirakawa
AKAkira Kugimiya
Akira Kugimiya
LALutfi Abu-Elheiga
Lutfi Abu-Elheiga
HCHea-Young Park Choo
Hea-Young Park Choo
MUMotonari Uesugi
Motonari Uesugi

1 May 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LALutfi Abu-Elheiga
Lutfi Abu-Elheiga
HWHongmei Wu
Hongmei Wu
ZGZiwei Gu
Ziwei Gu
SWSalih J. Wakil
Salih J. Wakil